Table 1.
Blood parameters and patient demographic measured in CFS/ME patients and NFC groups
| NFC (n = 9) | CFS/ME (n = 8) | P value | |
|---|---|---|---|
| Age (years) | 37.56 ± 11.06 | 48.63 ± 15.69 | 0.503 |
| Gender | |||
| Male n(%) | 3(33.3) | 1 (12.5) | |
| Female n(%) | 6 (66.7) | 7 (87.5) | |
| Pathology | |||
| White Cell Count (× 109/L) | 5.94 ± 1.61 | 5.45 ± 1.09 | 0.664 |
| Neutrophils (×109/L) | 3.54 ± 1.49 | 3.36 ± 0.82 | 0.847 |
| Lymphocytes (× 109/L) | 1.87 ± 0.38 | 1.70 ± 0.49 | 0.248 |
| Monocytes (× 109/L) | 0.32 ± 0.11 | 0.32 ± 0.06 | 0.962 |
| Eosinophils (× 109/L) | 0.18 ± 0.09 | 0.18 ± 0.12 | 0.885 |
| Platelet (× 109/L) | 240.78 ± 47.65 | 258.88 ± 37.13 | 0.413 |
| Haemoglobin (g/L) | 132.67 ± 8.51 | 135.38 ± 7.82 | 0.384 |
| Haematocrit | 0.37 ± 0.10 | 0.42 ± 0.03 | 0.191 |
| Red Cell Count (× 1012/L) | 4.53 ± 0.34 | 4.49 ± 0.34 | 0.923 |
| MCV fl | 89.67 ± 2.74 | 92.88 ± 5.11 | 0.222 |
Results from white and red blood cell parameters measured in CFS/ME and control groups. Comparisons of blood parameters between the CFS/ME and NFC revealed no significant differences. No significant differences were observed in patient age distribution. Data presented as mean ± standard deviation. Abbreviations: NFC, non-fatigued controls; CFS/ME, chronic fatigue syndrome; ME, Myalgic encephalomyelitis